Cargando…

Intracellular soluble α‐synuclein oligomers reduce pyramidal cell excitability

KEY POINTS: The presynaptic protein α‐synuclein forms aggregates during Parkinson's disease. Accumulating evidence suggests that the small soluble oligomers of α‐synuclein are more toxic than the larger aggregates appearing later in the disease. The link between oligomer toxicity and structure...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufmann, Timothy J., Harrison, Paul M., Richardson, Magnus J. E., Pinheiro, Teresa J. T., Wall, Mark J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865569/
https://www.ncbi.nlm.nih.gov/pubmed/26915902
http://dx.doi.org/10.1113/JP271968
_version_ 1782431800284413952
author Kaufmann, Timothy J.
Harrison, Paul M.
Richardson, Magnus J. E.
Pinheiro, Teresa J. T.
Wall, Mark J.
author_facet Kaufmann, Timothy J.
Harrison, Paul M.
Richardson, Magnus J. E.
Pinheiro, Teresa J. T.
Wall, Mark J.
author_sort Kaufmann, Timothy J.
collection PubMed
description KEY POINTS: The presynaptic protein α‐synuclein forms aggregates during Parkinson's disease. Accumulating evidence suggests that the small soluble oligomers of α‐synuclein are more toxic than the larger aggregates appearing later in the disease. The link between oligomer toxicity and structure still remains unclear. In the present study, we have produced two structurally‐defined oligomers that have a similar morphology but differ in secondary structure. These oligomers were introduced into neocortical pyramidal cells during whole‐cell recording and, using a combination of experimentation and modelling, electrophysiological parameters were extracted. Both oligomeric species had similar effects on neuronal properties reducing input resistance, time constant and increasing capacitance. The net effect was a marked reduction in neuronal excitability that could impact on network activity. ABSTRACT: The presynaptic protein α‐synuclein (αSyn) aggregates during Parkinson's disease (PD) to form large proteinaceous amyloid plaques, the spread of which throughout the brain clinically defines the severity of the disease. During early stages of aggregation, αSyn forms soluble annular oligomers that show greater toxicity than much larger fibrils. These oligomers produce toxicity via a number of possible mechanisms, including the production of pore‐forming complexes that permeabilize membranes. In the present study, two well‐defined species of soluble αSyn oligomers were produced by different protocols: by polymerization of monomer and by sonication of fibrils. The two oligomeric species produced were morphologically similar, with both having an annular structure and consisting of approximately the same number of monomer subunits, although they differed in their secondary structure. Oligomeric and monomeric αSyn were injected directly into the soma of pyramidal neurons in mouse neocortical brain slices during whole‐cell patch clamp recording. Using a combined experimental and modelling approach, neuronal parameters were extracted to measure, for the first time in the neocortex, specific changes in neuronal electrophysiology. Both species of oligomer had similar effects: (i) a significant reduction in input resistance and the membrane time constant and (ii) an increase in the current required to trigger an action potential with a resultant reduction in the firing rate. Differences in oligomer secondary structure appeared to produce only subtle differences in the activity of the oligomers. Monomeric αSyn had no effect on neuronal parameters, even at high concentrations. The oligomer‐induced fall in neuronal excitability has the potential to impact both network activity and cognitive processing.
format Online
Article
Text
id pubmed-4865569
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48655692016-11-22 Intracellular soluble α‐synuclein oligomers reduce pyramidal cell excitability Kaufmann, Timothy J. Harrison, Paul M. Richardson, Magnus J. E. Pinheiro, Teresa J. T. Wall, Mark J. J Physiol Neuroscience ‐ Neurobiology of Disease KEY POINTS: The presynaptic protein α‐synuclein forms aggregates during Parkinson's disease. Accumulating evidence suggests that the small soluble oligomers of α‐synuclein are more toxic than the larger aggregates appearing later in the disease. The link between oligomer toxicity and structure still remains unclear. In the present study, we have produced two structurally‐defined oligomers that have a similar morphology but differ in secondary structure. These oligomers were introduced into neocortical pyramidal cells during whole‐cell recording and, using a combination of experimentation and modelling, electrophysiological parameters were extracted. Both oligomeric species had similar effects on neuronal properties reducing input resistance, time constant and increasing capacitance. The net effect was a marked reduction in neuronal excitability that could impact on network activity. ABSTRACT: The presynaptic protein α‐synuclein (αSyn) aggregates during Parkinson's disease (PD) to form large proteinaceous amyloid plaques, the spread of which throughout the brain clinically defines the severity of the disease. During early stages of aggregation, αSyn forms soluble annular oligomers that show greater toxicity than much larger fibrils. These oligomers produce toxicity via a number of possible mechanisms, including the production of pore‐forming complexes that permeabilize membranes. In the present study, two well‐defined species of soluble αSyn oligomers were produced by different protocols: by polymerization of monomer and by sonication of fibrils. The two oligomeric species produced were morphologically similar, with both having an annular structure and consisting of approximately the same number of monomer subunits, although they differed in their secondary structure. Oligomeric and monomeric αSyn were injected directly into the soma of pyramidal neurons in mouse neocortical brain slices during whole‐cell patch clamp recording. Using a combined experimental and modelling approach, neuronal parameters were extracted to measure, for the first time in the neocortex, specific changes in neuronal electrophysiology. Both species of oligomer had similar effects: (i) a significant reduction in input resistance and the membrane time constant and (ii) an increase in the current required to trigger an action potential with a resultant reduction in the firing rate. Differences in oligomer secondary structure appeared to produce only subtle differences in the activity of the oligomers. Monomeric αSyn had no effect on neuronal parameters, even at high concentrations. The oligomer‐induced fall in neuronal excitability has the potential to impact both network activity and cognitive processing. John Wiley and Sons Inc. 2016-03-24 2016-05-15 /pmc/articles/PMC4865569/ /pubmed/26915902 http://dx.doi.org/10.1113/JP271968 Text en © 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Neuroscience ‐ Neurobiology of Disease
Kaufmann, Timothy J.
Harrison, Paul M.
Richardson, Magnus J. E.
Pinheiro, Teresa J. T.
Wall, Mark J.
Intracellular soluble α‐synuclein oligomers reduce pyramidal cell excitability
title Intracellular soluble α‐synuclein oligomers reduce pyramidal cell excitability
title_full Intracellular soluble α‐synuclein oligomers reduce pyramidal cell excitability
title_fullStr Intracellular soluble α‐synuclein oligomers reduce pyramidal cell excitability
title_full_unstemmed Intracellular soluble α‐synuclein oligomers reduce pyramidal cell excitability
title_short Intracellular soluble α‐synuclein oligomers reduce pyramidal cell excitability
title_sort intracellular soluble α‐synuclein oligomers reduce pyramidal cell excitability
topic Neuroscience ‐ Neurobiology of Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865569/
https://www.ncbi.nlm.nih.gov/pubmed/26915902
http://dx.doi.org/10.1113/JP271968
work_keys_str_mv AT kaufmanntimothyj intracellularsolubleasynucleinoligomersreducepyramidalcellexcitability
AT harrisonpaulm intracellularsolubleasynucleinoligomersreducepyramidalcellexcitability
AT richardsonmagnusje intracellularsolubleasynucleinoligomersreducepyramidalcellexcitability
AT pinheiroteresajt intracellularsolubleasynucleinoligomersreducepyramidalcellexcitability
AT wallmarkj intracellularsolubleasynucleinoligomersreducepyramidalcellexcitability